Washington, D.C. – The National Coalition on Health Care (NCHC) released a statement opposing the the Administration’s approach to address drug pricing through the two rules released Friday, November 20.
The rules – removing the current rebate safe harbor in Medicare Part D and establishing a “Most Favored Nation” Model in Part B – rightly recognize the urgency of addressing exorbitant drug prices, especially during the twin public health and economic crisis of the coronavirus pandemic. However, the Coalition believes that these hasty rules will only burden future efforts by a new Congress to make necessary and sustainable changes to our drug pricing system.
“Good intentions will not save seniors from high drug prices,” said John Rother, President of the National Coalition on Health Care. “We should look to the next Congress to make comprehensive change that avoids cost-shifting, easily anticipated court battles, or unintended consequences.”